Back to User profile » Dr Yu-Chih Liu

Papers published by Dr Yu-Chih Liu:

Corrigendum

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]

Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH

Drug Design, Development and Therapy 2021, 15:515-516

Published Date: 12 February 2021

Clinical Trial Report

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH

Drug Design, Development and Therapy 2020, 14:5441-5450

Published Date: 8 December 2020

Original Research

Amino Acid-Based Metabolic Indexes Identify Patients With Chronic Obstructive Pulmonary Disease And Further Discriminates Patients In Advanced BODE Stages

Kuo WK, Liu YC, Chu CM, Hua CC, Huang CY, Liu MH, Wang CH

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2257-2266

Published Date: 30 September 2019